Home
Browse All Titles
Sign In
Browse All Titles
TNM Cancer Staging Manual
About
Table of Contents
Main Index
Table Index
Image Index
TNM Calculators Index
Medication Index
ICD Code Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
*
A
C
D
E
F
H
I
K
L
M
N
O
P
R
S
T
U
V
▶
View All
Recurrence-free and overall survival for patients treated with 1 versus 3 years of imatinib for higher-risk GIST, defined as having at least one of the following features: (1) longest tumor diameter greater than 10
Regional lymph nodes for skin sites of the head and neck
Regional lymph nodes for the vagina
Regional lymph nodes of the adrenal gland
Regional lymph nodes of the corpus uteri
Regional lymph nodes of the kidney
Regional lymph nodes of the penis
Regional lymph nodes of the stomach
Regional lymph nodes of the vulva
Relative Age Adjusted Incidence of Brain Tumors (from Ostrom et al
Risk-adjusted survival after treatment decision for clinically staged (c) adenocarcinoma of the esophagus based on WECC data
Risk-adjusted survival after treatment decision for pathologically staged (p) adenocarcinoma of the esophagus based on WECC data
Regional lymph nodes for NETs of the colon and rectum
Regional lymph nodes for the cervix uteri
Regional lymph nodes of ovary, fallopian tube and primary peritoneal carcinomas
Regional lymph nodes of the anal canal
Regional lymph nodes of the duodenum and ampulla of Vater
Regional lymph nodes of the pancreas (anterior view)
Regional lymph nodes of the pleura
Regional lymph nodes of the urethra
Regional percent of body surface area in the adult (From Olsen et al
Relative survival of colon and rectal carcinoma patients in the SEER database since the TNM 7th Edition was introduced in January 2010
Risk-adjusted survival after treatment decision for clinically staged (c) squamous cell carcinoma of the esophagus based on Worldwide Esophageal Cancer Collaboration (WECC) data
Risk-adjusted survival after treatment decision for pathologically staged (p) squamous cell carcinoma of the esophagus based on WECC data
Risk-adjusted survival after treatment decision for postneoadjuvant pathologically staged (yp) squamous cell carcinoma of the esophagus based on WECC data
Risk-adjusted survival after treatment decision for postneoadjuvant pathologically staged (yp) adenocarcinoma of the esophagus based on WECC data
Refresh
first
prev
1
30
select
next
last
Displaying items 1 - 26 of 26
